USPTO serial 87348251
ATHENEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 28, 2020
- Examiner
- WELLS, KELLEY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ATHENEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline M. Lesser
Jacqueline M. Lesser BAKER & HOSTETLER LLP2929 ARCH STREETCIRA CENTRE, 12TH FLOORPHILADELPHIA, PA 19104-2891Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Prescription pharmaceuticals directed to treatment of diseases and disorders affecting the circulatory system, digestive system, excretory system, endocrine system, integumentary system/exocrine system, immune system and lymphatic system, muscular system, nervous system, renal system and urinary system, reproductive system, respiratory system, skeletal system, impacting the blood, brain, heart, lungs, kidneys, stomach, liver, pancreas, mammary glands, ovaries, uterus, testes, bladder, rectum, large intestine, small intestine, gall bladder, hair, skin, nails, muscles, bones, joints, tendons, spine, thymus, thyroid, lymph nodes, spleen, eyes, nose, trachea, esophagus, including anti-infectives, anti-emetics, narcotics/analgesics, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations for the treatment of dermatological conditions, pharmaceutical products for the treatment of cancer, anesthesia and sedatives, pain relief, anti-inflammatory preparations, antiepileptic agents, muscle relaxants | ACTIVE | Feb 8, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 28, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 28, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 11, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 11, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 31, 2019 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Dec 31, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 31, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 31, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 31, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 31, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 18, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 13, 2019 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Dec 13, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Dec 13, 2019 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jun 14, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 14, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 14, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 5, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 2, 2019 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 21, 2018 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 19, 2018 | ALIE | ASSIGNED TO LIE | — |
| Dec 3, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 3, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 3, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 1, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 20, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 3, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 2, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 28, 2017 | NWAP | NEW APPLICATION ENTERED | — |